Gyldendal A/S
CSE:GYLD B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gyldendal A/S
CSE:GYLD B
|
DK |
|
D
|
Douglas AG
XETRA:DOU
|
DE |
|
Norfolk Southern Corp
NYSE:NSC
|
US |
|
Guiyang Xintian Pharmaceutical Co Ltd
SZSE:002873
|
CN |
|
W
|
Welspun Enterprises Ltd
NSE:WELENT
|
IN |
|
K
|
Kip Real Estate Investment Trust
KLSE:KIPREIT
|
MY |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GYLD B's stock price target?
Not Available
GYLD B doesn't have any price targets made by Wall Street professionals.
What is Gyldendal A/S's Revenue forecast?
Projected CAGR
1%
For the last 9 years the
compound annual growth rate for
Gyldendal A/S's revenue is
0%.
The projected
CAGR
for the next 7 years is
1%.
What is Gyldendal A/S's Operating Income forecast?
Projected CAGR
-6%
For the last 9 years the
compound annual growth rate for
Gyldendal A/S's operating income is
-1%.
The projected
CAGR
for the next 7 years is
-6%.
What is Gyldendal A/S's Net Income forecast?
Projected CAGR
-3%
For the last 9 years the
compound annual growth rate for
Gyldendal A/S's net income is
-2%.
The projected
CAGR
for the next 7 years is
-3%.
